SLC2A1 and non-small cell lung carcinoma: Koh et al. [25] studied, in 269 patients treated with surgical resection for NSCLC, the following criteria: (a) the metabolic tumor volume (MTV) and total lesion glycolysis (TLG) values, by preoperative 18F-FDG-PET/CT; and (b) the expression of GLUT-1.